Additionally, the use of DC vaccines loaded with specific HCC antigens (e.g., AFP or GPC-3) in combination with CTLA-4 inhibitors (e.g., Ipilimumab) not only remodeled the TME but also further amplified the immune effects by decreasing the number and function of Tregs and MDSCs [118]. This evidence concerns the gene AFP and hepatocellular carcinoma.